Pharmaceutical formulations comprising the BPI fragments of the present invention (or physiologically-acoeptable salts thereof) as at least one of the active ingredients, would in addition comprise pharmaceutically-aoceptable carriers, diluents, fillers, salts and other materials well-known in the art depending upon the dosage form utilized.